2018 tables: Institutions - corporate

Table criteria

The 2018 tables are based on Nature Index data from 1 January 2017 to 31 December 2017.

2017 Institution FC 2016 FC 2017
1 F. Hoffmann-La Roche AG, Switzerland 43.91 53.69
2 IBM Corporation, United States of America (USA) 42.89 47.7
3 Novartis International AG, Switzerland 41.29 41.55
4 Merck & Co., Inc., United States of America (USA) 29.74 35.1
5 AstraZeneca plc, United Kingdom (UK) 31.15 29.87
6 Pfizer Inc., United States of America (USA) 27.72 23.3
7 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 17.92 16.66
8 GNS Science, New Zealand 10.85 16.12
9 Samsung Group, South Korea 19.37 15.09
10 Amgen Inc., United States of America (USA) 20.35 14.75
11 Bristol-Myers Squibb (BMS), United States of America (USA) 6.5 14.54
12 DowDuPont Inc., United States of America (USA) 14.34 12.78
13 Johnson & Johnson, United States of America (USA) 7.77 11.63
14 Microsoft Corporation, United States of America (USA) 11.06 11.62
15 Alphabet Inc., United States of America (USA) 11.58 9.31
16 Eli Lilly and Company, United States of America (USA) 9.79 9.12
17 AbbVie Inc., United States of America (USA) 2.23 8.51
18 BASF SE, Germany 12.76 8.08
19 Toyota Group, Japan 12.79 7.99
20 Toshiba Corporation, Japan 7.3 7.91
21 China Shipbuilding Industry Corporation (CSIC), China 5.13 7.91
22 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 7.31 7.81
23 Thermo Fisher Scientific Inc., United States of America (USA) 8.49 7.62
24 Formosa Plastics Group, Taiwan 7.02 7.52
25 FiberHome Technologies Group, China 5.15 7.28
26 Nippon Telegraph and Telephone Corporation (NTT), Japan 16.61 7.11
27 Biogen Inc., United States of America (USA) 4.54 6.96
28 Bruker Corporation, United States of America (USA) 4.88 6.68
29 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 10.8 6.34
30 Science Systems and Applications, Inc. (SSAI), United States of America (USA) 6.84 5.88
31 Novo Nordisk A/S, Denmark 4.36 5.86
32 BGI, China 5.71 5.63
33 Takeda Pharmaceutical Company Limited, Japan 2.69 5.52
34 NorthWest Research Associates, Inc. (NWRA), United States of America (USA) 1.74 4.98
35 Regeneron Pharmaceuticals, Inc., United States of America (USA) 4.57 4.95
36 Hitachi, Ltd., Japan 4.57 4.83
37 China National Chemical Corporation (ChemChina), China 3.01 4.67
38 Chevron Corporation, United States of America (USA) 3.29 4.66
39 Sanofi, France 3.94 4.61
40 GATS Inc., United States of America (USA) 2.22 4.58
41 Leidos Holdings, Inc., United States of America (USA) 5.36 4.21
42 China Aerospace Science and Technology Corporation (CASC), China 1.44 4.2
43 Western Digital Corporation, United States of America (USA) 5.23 4.2
44 Thales S.A., France 6.06 4.11
45 National Institute of Water and Atmospheric Research Ltd. (NIWA), New Zealand 5.6 4
46 Jinchuan Group Co., Ltd., China 1.74 3.91
47 Merck KGaA, Germany 3.93 3.88
48 UCB S.A., Belgium 1.5 3.87
49 HP Inc., United States of America (USA) 6.66 3.76
50 Bayer AG, Germany 5.37 3.76
51 Mitsubishi Group, Japan 3.69 3.69
52 Human Longevity, Inc., United States of America (USA) 0.99 3.67
53 New England Biolabs, Inc. (NEB), United States of America (USA) 2.9 3.63
54 Schlumberger Limited, United States of America (USA) 1.69 3.58
55 Ionis Pharmaceuticals, Inc., United States of America (USA) 4.24 3.45
56 AIT Austrian Institute of Technology GmbH, Austria 1.92 3.43
57 Nestlé S.A., Switzerland 3.43 3.41
58 Agilent Technologies, Inc., United States of America (USA) 2.53 3.3
59 China National Tobacco Company (CNTC), China 0.43 3.29
60 Waters Corporation, United States of America (USA) 2.18 3.27
61 Illumina, Inc., United States of America (USA) 2.71 3.2
62 Solvay S.A., Belgium 1.59 3.03
63 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 3.62 2.95
64 Danaher Corporation, United States of America (USA) 1.59 2.89
65 Lockheed Martin Corporation, United States of America (USA) 1.6 2.87
66 Airbus S.A.S., France 0.88 2.82
67 Chengdu Institute of Organic Chemistry (CIOC), CAS, China 1.92 2.72
68 Equinor ASA, Norway 0.43 2.69
69 HRL Laboratories LLC, United States of America (USA) 5.75 2.63
70 H3 Biomedicine Inc., United States of America (USA) 0.5 2.58
71 Intel Corporation, United States of America (USA) 2.43 2.56
72 NGM Biopharmaceuticals, Inc., United States of America (USA) 0.64 2.54
73 Rigaku Corporation, Japan 0.92 2.48
74 Unilever, United Kingdom (UK) 1.86 2.46
75 Infineon Technologies AG, Germany 0.06 2.43
76 Joel Ltd., Japan 3.1 2.42
77 Synthetic Genomics, Inc. (SGI), United States of America (USA) 1.4 2.3
78 Foundation Medicine, Inc., United States of America (USA) 1.04 2.27
79 Eisai Co., Ltd., Japan 1.77 2.27
80 Jacobs, United States of America (USA) 1.65 2.25
81 Uni Research Ltd., Norway 3.13 2.23
82 South Australian Water Corporation (SA Water), Australia 1.26 2.23
83 Sony Corporation, Japan 1.05 2.21
84 Northrop Grumman Corporation, United States of America (USA) 1.75 2.19
85 Techint Group, Italy 0.91 2.17
86 Haldor Topsøe A/S, Denmark 2.13 2.14
87 Johnson Matthey (JM), United Kingdom (UK) 2.02 2.12
88 Austrian Centre of Industrial Biotechnology (ACIB), Austria 1.17 2.1
89 Total S.A., France 2.18 2.08
90 Koninklijke Philips N.V. (Philips), Netherlands 0.84 2.06
91 Aerodyne Research, Inc. (ARI), United States of America (USA) 1.91 2.03
92 Nokia Corporation, Finland 1.22 2.03
93 FujiFilm Corporation, Japan 0.45 2.01
94 10x Genomics, United States of America (USA) 1.12 2.01
95 Seattle Genetics, Inc., United States of America (USA) 3.03 2
95 Soraa Inc., United States of America (USA) 2 2
96 China Electronics Technology Group Corporation (CETC), China 1.44 1.97
97 Shimadzu Corporation, Japan 2.74 1.97
98 Earlham Institute (EI), United Kingdom (UK) 1.01 1.95
99 Royal Dutch Shell plc (Shell), Netherlands 4.69 1.88
100 Koninklijke DSM N.V. (DSM), Netherlands 2.18 1.82

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. It is important for users to understand that the data behind the tables are based on a relatively small proportion of total research papers, that they cover the natural sciences only and that outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output). We encourage users to combine the free-to-access Nature Index data with information from other sources.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted FC accounts for the small annual variation in the total number of articles in Nature Index journals. FC values have been adjusted to 2018 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.